作者
Chris J Malkin, Peter J Pugh, John N West, Edwin JR van Beek, T Hugh Jones, Kevin S Channer
发表日期
2006/1/1
期刊
European heart journal
卷号
27
期号
1
页码范围
57-64
出版商
Oxford University Press
简介
Aims Chronic heart failure is associated with maladaptive and prolonged neurohormonal and pro-inflammatory cytokine activation causing a metabolic shift favouring catabolism, vasodilator incapacity, and loss of skeletal muscle bulk and function. In men, androgens are important determinants of anabolic function and physical strength and also possess anti-inflammatory and vasodilatory properties.
Methods and results We conducted a randomized, double-blind, placebo-controlled parallel trial of testosterone replacement therapy (5 mg Androderm®) at physiological doses in 76 men (mean±SD, age 64±9.9) with heart failure (ejection fraction 32.5±11%) over a maximum follow-up period of 12 months. The primary endpoint was functional capacity as assessed by the incremental shuttle walk test (ISWT). At baseline, 18 (24%) had serum testosterone below the normal range and bioavailable …
引用总数
2006200720082009201020112012201320142015201620172018201920202021202220232024162728304042233433393819302920141999
学术搜索中的文章